Drug
Bgb Dxp604
Bgb Dxp604: highest development phase Phase 1, developed by BeiGene. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BeiGene
Trials
| Drug | Phase | Indication |
|---|---|---|
| BGB-DXP604 NCT04669262 | Phase 1 | Healthy |
Latest
No recent events.
Follow Bgb Dxp604 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.